Rising Insulin Costs
A growing number of people who have Type 1 diabetes, which requires daily insulin, are going without that vital medicine, or making potentially fatal reductions in their doses, due to the skyrocketing cost of insulin, Mike Patrick discusses this health care crisis with Ray Kimmelblatt, Executive Director of JDRF (formerly the Juvenile Diabetes Research Foundation) and looks at options for reducing those costs.